The Moving Average Convergence Divergence (MACD) for AHG turned positive on September 14, 2026. Looking at past instances where AHG's MACD turned positive, the stock continued to rise in 48 of 52 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on September 30, 2026. You may want to consider a long position or call options on AHG as a result. In 101 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
AHG moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AHG crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 20 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +10.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where AHG advanced for three days, in 148 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AHG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
AHG broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AHG entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. AHG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.461) is normal, around the industry mean (2.488). P/E Ratio (40.650) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. AHG's P/S Ratio (38.911) is very high in comparison to the industry average of (4.260).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AHG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
RWAY moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend. In 27 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 66%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RWAY as a result. In 57 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The 10-day moving average for RWAY crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RWAY's RSI Indicator exited the oversold zone, 21 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 50-day moving average for RWAY moved above the 200-day moving average on October 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where RWAY advanced for three days, in 153 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
RWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 109 of 225 cases where RWAY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 48%.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.558) is normal, around the industry mean (3.263). P/E Ratio (27.917) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (1.152) is also within normal values, averaging (1.319). RWAY has a moderately high Dividend Yield (0.197) as compared to the industry average of (0.081). P/S Ratio (11.013) is also within normal values, averaging (15.860).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. RWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RWAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
AHG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 49 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 37 | |
P/E GROWTH RATING 1..100 | 2 | |
SEASONALITY SCORE 1..100 | 1 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AHG | RWAY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 90% | N/A |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 58% |
| Advances ODDS (%) | 2 days ago 80% | 22 days ago 56% |
| Declines ODDS (%) | 16 days ago 90% | 8 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 48% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AHG’s FA Score shows that 1 FA rating(s) are green while RWAY’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AHG’s TA Score shows that 5 TA indicator(s) are bullish while RWAY’s TA Score has 6 bullish TA indicator(s).
AHG (@Medical Distributors) experienced а +19.49% price change this week, while RWAY (@Investment Managers) price change was +0.39% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.14%. For the same industry, the average monthly price growth was +2.85%, and the average quarterly price growth was -20.81%.
The average weekly price growth across all stocks in the @Investment Managers industry was -3.37%. For the same industry, the average monthly price growth was -2.77%, and the average quarterly price growth was -3.95%.
RWAY is expected to report earnings on Nov 05, 2026.
Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Investment Managers (-3.37% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OPP | 6.93 | 0.01 | +0.14% |
| RiverNorth/DoubleLine Strategic Opportunity Fund | |||
| TMSF | 48.85 | -0.02 | -0.03% |
| T. Rowe Price Multi-Sector Income ETF (TMSF) | |||
| QSML | 33.26 | -0.03 | -0.09% |
| WisdomTree U.S. SmallCap Quality Growth Fund (QSML) | |||
| ULTY | 25.18 | -0.14 | -0.55% |
| YieldMax Ultra Option Income Strategy ETF (ULTY) | |||
| IBB | 200.02 | -4.24 | -2.08% |
| iShares Biotechnology ETF (IBB) | |||